Development (D)

IND Enabling Programs

Our process development platform is defined and designed to ensure scale up directly from bench scale to clinical batch manufacturing in a timely manner. From DNA to IND, we can achieve it in as short as 12 months.

  • Dedicated 200 to 500L production bioreactors
  • Single use technology
  • Flexible platforms from Cytiva, Thermo Fisher, and Sartorius
  • GMP ready

CLB 12-month DNA to IND program